Stay updated with the latest developments in Paediatric Gastroenterology, Hepatology, and Nutrition (PGHN) and get to know the experts behind the research and our organisation. The official podcast of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) explores cutting-edge studies, practice management strategies, and more. Join us three times a month for insightful interviews and commentary with leading professionals in the field, designed to enhance your knowledge and advance your expertise.
Our podcast features specialists from around the world, with a particular emphasis on the European community.
This podcast is hosted by the ESPGHAN Education Committee.
Disclaimer: Opinions expressed in this podcast are those of the guest invited and do not necessarily reflect the views or positions of ESPGHAN. These opinions are based on information and scientific data available at the time of recording and may change as research in the field advances.
New Episodes 1st, 10th and 20th of the Month. For feedback, contact us: office@espghan.org | Playlist: ESPGHAN favourite Songs can be found on Spotify https://open.spotify.com/playlist/0YIHKjxITLEm9XNyHyypTo
Producer: Selma Ertl, MBA | Host: Dr. Alex Knisely | Recording: Manuel Schuster
Stay updated with the latest developments in Paediatric Gastroenterology, Hepatology, and Nutrition (PGHN) and get to know the experts behind the research and our organisation. The official podcast of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) explores cutting-edge studies, practice management strategies, and more. Join us three times a month for insightful interviews and commentary with leading professionals in the field, designed to enhance your knowledge and advance your expertise.
Our podcast features specialists from around the world, with a particular emphasis on the European community.
This podcast is hosted by the ESPGHAN Education Committee.
Disclaimer: Opinions expressed in this podcast are those of the guest invited and do not necessarily reflect the views or positions of ESPGHAN. These opinions are based on information and scientific data available at the time of recording and may change as research in the field advances.
New Episodes 1st, 10th and 20th of the Month. For feedback, contact us: office@espghan.org | Playlist: ESPGHAN favourite Songs can be found on Spotify https://open.spotify.com/playlist/0YIHKjxITLEm9XNyHyypTo
Producer: Selma Ertl, MBA | Host: Dr. Alex Knisely | Recording: Manuel Schuster

Dr Eytan Wine was graduated from the School of Medicine at Tel Aviv University in 1998, with training in paediatrics at Wolfson Medical Center in Holon, Israel, followed by specialty training in gastroenterology, hepatology, and nutrition at the Hospital for Sick Children in Toronto, where he also earned a PhD degree for studies in bacterially induced intestinal inflammation.
His first position as an attending physician began in 2009 at the Stollery Children’s Hospital in Edmonton, Alberta, where in 2021 he was appointed to a professorship of paediatrics at the University of Alberta – which he has just left to work again in Toronto at the Hospital for Sick Children.
His academic interests have centred on the interplay among diet, enteral microbiome, and intestinal inflammation.
When interviewed in Helsinki, at the 2025 annual meeting of ESPGHAN, he chose, however, rather than to concentrate on his contributions in this area, instead to address the important clinical question of:
How to select initial therapy and
How to progress to longer-term therapy in patients with inflammatory bowel disease, given the sometimes bewildering array of options in both testing and treatment.
He asks:
What are the best treatments for paediatric inflammatory bowel disease in 2025, and how do we define "best"?
How do we navigate a world with so many therapy options and choose the ‘best’ one for an individual patient?
Finally, does the order matter in which we deploy the weapons in our armamentarium?
Do we start with our most effective therapy or keep it for refractory cases only?
All this, with the ground beneath us continually quaking and shifting...
To specialise in the care of patients with inflammatory bowel disease requires substantial effort.With a guide like Dr Wine, however, one can be more confident that one is choosing well – as the references below demonstrate.
Literature
Bressler B. Is there an optimal sequence of biologic therapies for inflammatory bowel disease? Therap Adv Gastroenterol 2023 Apr 5; 16:17562848231159452.Doi: 10.1177/17562848231159452. eCollection 2023. PMID: 37057077. PMCID: PMC10087655
Spencer EA. Choosing the right therapy at the right time for pediatric inflammatory bowel disease: Does sequence matter. Gastroenterol Clin North Am 2023 Sep; 52(3):517-534.Doi: 10.1016/j.gtc.2023.05.006. PMID: 37543397
Noor NM et al. Review article: Novel therapies in inflammatory bowel disease - An update for clinicians. Aliment Pharmacol Ther 2024 Nov; 60(9):1244-1260.Doi: 10.1111/apt.18294. PMID: 39403052
Dr. Wine´s favourite song: Michael Jakson - We are the world
ESPGHAN favourite Songs can be found on Spotify https://open.spotify.com/playlist/0YIHKjxITLEm9XNyHyypTo